Federal Circuit affirms MINOCIN patent validity and infringement against Nexus

CorMedix's subsidiary Melinta won a patent litigation case where the Federal Circuit upheld findings that Nexus Pharmaceuticals infringed MINOCIN patents and affirmed a permanent injunction blocking generic competition. The decision protects CorMedix's market exclusivity for its intravenous minocycline product until patent expiration.